{"applicableToSamples":"ALL","active":true,"applicableBlocks":["PATIENT_INFO","SECTION","NON_GLIOMA_PATHOGENIC","SNV_PINNED","SNV_MANUAL","SIGN_PLACE","CNV_QUERY","GLIOMA_PATHOGENIC","FORMATTED_TEXT","SNV_ACMG_SF","GLIOMA_ASSOCIATED","ONCO_RELEVANT_SNV_MANUAL","SAMPLE_INFO","DISCLAIMER","SNV_QUERY","CLINICAL_TRIALS","ONCO_RECOMMENDATIONS","CLINVAR_PHENOTYPES"],"blocks":[{"id":"92599d5a-0681-48eb-b5e5-5e7624de5456","reportTemplateId":"65221598-08a5-44b7-88c2-a70d522f8c94","type":"SNV_ACMG_SF","ordering":0,"parameters":{"name":"ACMG secondary findings","description":"Variants in genes from the list of American College of Medical Genetics and Genomics, which ACMG recommends to be reported.","origin":"GERMLINE","maxGnomadFreq":0.03,"interpretationMode":"BY_VARIANTS","transferVariantInterpretationToGeneral":false,"interpretation":"ACMG Secondary Findings interpretation guidelines should be followed for reporting pathogenic and likely pathogenic variants.","useFirstTierResultsAsPotentialFindings":false,"useSecondTierResultsAsPotentialFindings":false}}],"createdAt":"2026-02-26T16:43:47.571Z","updatedAt":"2026-03-03T15:09:09.436Z","id":"65221598-08a5-44b7-88c2-a70d522f8c94","ownerId":"88edbf10-b671-4c15-b1df-4fe81158696c","shortName":"ACMG SF","fullName":null,"description":null}